BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, Shiraishi K, Okuda H, Onji M, Kanazawa H, Tsubouchi H, Kato S, Kaito M, Watanabe A, Habu D, Ito S, Ishikawa T, Kawamura N, Arakawa Y; Hepatic Nutritional Therapy (HNT) Study Group. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition. 2007;23:113-120. [PMID: 17234504 DOI: 10.1016/j.nut.2006.10.008] [Cited by in Crossref: 125] [Cited by in F6Publishing: 110] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Ooi PH, Gilmour SM, Yap J, Mager DR. Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: A systematic review. Clin Nutr ESPEN 2018;28:41-51. [PMID: 30390892 DOI: 10.1016/j.clnesp.2018.07.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
2 Silva M, Gomes S, Peixoto A, Torres-Ramalho P, Cardoso H, Azevedo R, Cunha C, Macedo G. Nutrition in Chronic Liver Disease. GE Port J Gastroenterol 2015;22:268-76. [PMID: 28868418 DOI: 10.1016/j.jpge.2015.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
3 Nishikawa H, Osaki Y, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Henmi S, Sakamoto A, Ishikawa T, Saito S, Kita R, Kimura T. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2012; 18(12): 1379-1384 [PMID: 22493552 DOI: 10.3748/wjg.v18.i12.1379] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
4 Holecek M. Branched-chain amino acids and ammonia metabolism in liver disease: Therapeutic implications. Nutrition 2013;29:1186-91. [DOI: 10.1016/j.nut.2013.01.022] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 6.3] [Reference Citation Analysis]
5 Hanai T, Shiraki M, Nishimura K, Imai K, Suetsugu A, Takai K, Shimizu M, Naiki T, Moriwaki H. Free fatty acid as a marker of energy malnutrition in liver cirrhosis. Hepatol Res. 2014;44:218-228. [PMID: 23601060 DOI: 10.1111/hepr.12112] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
6 Mann G, Mora S, Madu G, Adegoke OAJ. Branched-chain Amino Acids: Catabolism in Skeletal Muscle and Implications for Muscle and Whole-body Metabolism. Front Physiol 2021;12:702826. [PMID: 34354601 DOI: 10.3389/fphys.2021.702826] [Reference Citation Analysis]
7 Kawaguchi T, Taniguchi E, Itou M, Mutou M, Ibi R, Shiraishi S, Okada T, Uchida Y, Otsuka M, Tonan T, Fujimoto K, Oriishi T, Tanaka S, Takakura M, Sata M. Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis. Hepatol Res 2008;38:1178-85. [PMID: 18631252 DOI: 10.1111/j.1872-034X.2008.00390.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
8 Koreeda C, Seki T, Okazaki K, Ha-Kawa SK, Sawada S. Effects of late evening snack including branched-chain amino acid on the function of hepatic parenchymal cells in patients with liver cirrhosis. Hepatol Res. 2011;41:417-422. [PMID: 21518402 DOI: 10.1111/j.1872-034x.2011.00795.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Koretz RL, Avenell A, Lipman TO. Nutritional support for liver disease. Cochrane Database Syst Rev 2012;:CD008344. [PMID: 22592729 DOI: 10.1002/14651858.CD008344.pub2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
10 Masuda T, Shirabe K, Yoshiya S, Matono R, Morita K, Hashimoto N, Ikegami T, Yoshizumi T, Baba H, Maehara Y. Nutrition support and infections associated with hepatic resection and liver transplantation in patients with chronic liver disease. JPEN J Parenter Enteral Nutr. 2013;37:318-326. [PMID: 22898793 DOI: 10.1177/0148607112456041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
11 Shimizu M, Shirakami Y, Hanai T, Imai K, Suetsugu A, Takai K, Shiraki M, Moriwaki H. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids. Mol Nutr Food Res 2014;58:124-35. [PMID: 24273224 DOI: 10.1002/mnfr.201300538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
12 Zhou YJ, Yu ZJ. Nutritional assessment and treatment in patients with liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2014; 22(31): 4750-4756 [DOI: 10.11569/wcjd.v22.i31.4750] [Reference Citation Analysis]
13 Nojiri S, Fujiwara K, Shinkai N, Iio E, Joh T. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial. Nutrition 2017;33:20-7. [DOI: 10.1016/j.nut.2016.07.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
14 Shuja A, Malespin M, Scolapio J. Nutritional Considerations in Liver Disease. Gastroenterol Clin North Am 2018;47:243-52. [PMID: 29413017 DOI: 10.1016/j.gtc.2017.09.010] [Reference Citation Analysis]
15 Ruiz-Margáin A, Méndez-Guerrero O, Román-Calleja BM, González-Rodríguez S, Fernández-Del-Rivero G, Rodríguez-Córdova PA, Torre A, Macías-Rodríguez RU. Dietary management and supplementation with branched-chain amino acids in cirrhosis of the liver. Rev Gastroenterol Mex (Engl Ed) 2018;83:424-33. [PMID: 30292583 DOI: 10.1016/j.rgmx.2018.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Yoshida R, Yagi T, Sadamori H, Matsuda H, Shinoura S, Umeda Y, Sato D, Utsumi M, Nagasaka T, Okazaki N. Branched-chain amino acid-enriched nutrients improve nutritional and metabolic abnormalities in the early post-transplant period after living donor liver transplantation. J Hepatobiliary Pancreat Sci. 2012;19:438-448. [PMID: 21947604 DOI: 10.1007/s00534-011-0459-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
17 Hey P, Gow P, Testro AG, Apostolov R, Chapman B, Sinclair M. Nutraceuticals for the treatment of sarcopenia in chronic liver disease. Clin Nutr ESPEN 2021;41:13-22. [PMID: 33487256 DOI: 10.1016/j.clnesp.2020.11.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
18 Pilar Milke García MD. Nutritional support in the treatment of chronic hepatic encephalopathy. Annals of Hepatology 2011;10:S45-9. [DOI: 10.1016/s1665-2681(19)31606-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Wang Y, Zhai YZ, Feng GH. Nutritional and metabolic abnormalities and nutrition support therapy in patients with liver failure. Shijie Huaren Xiaohua Zazhi 2012; 20(23): 2167-2172 [DOI: 10.11569/wcjd.v20.i23.2167] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Kanekawa T, Nagai H, Kanayama M, Sumino Y. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy. Cancer Chemother Pharmacol 2014;74:899-909. [PMID: 25138286 DOI: 10.1007/s00280-014-2564-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015;31:193-199. [PMID: 25441595 DOI: 10.1016/j.nut.2014.07.005] [Cited by in Crossref: 201] [Cited by in F6Publishing: 181] [Article Influence: 25.1] [Reference Citation Analysis]
22 Bavaro DF, Laghetti P, Poliseno M, De Gennaro N, Di Gennaro F, Saracino A. A Step Closer to the "Fourth 90": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV. Diagnostics (Basel) 2021;11:2047. [PMID: 34829394 DOI: 10.3390/diagnostics11112047] [Reference Citation Analysis]
23 Yamasaki T, Sakaida I. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma and future treatments for the poor responders. Hepatol Res. 2012;42:340-348. [PMID: 22151009 DOI: 10.1111/j.1872-034x.2011.00938.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
24 Valerio A, D'Antona G, Nisoli E. Branched-chain amino acids, mitochondrial biogenesis, and healthspan: an evolutionary perspective. Aging (Albany NY) 2011;3:464-78. [PMID: 21566257 DOI: 10.18632/aging.100322] [Cited by in Crossref: 105] [Cited by in F6Publishing: 91] [Article Influence: 9.5] [Reference Citation Analysis]
25 Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Okudaira T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Kohgami S, Hirooka M, Tokumoto Y, Abe M, Matsuura B, Hiasa Y. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416-1423. [PMID: 29016470 DOI: 10.1097/meg.0000000000000986] [Cited by in Crossref: 65] [Cited by in F6Publishing: 30] [Article Influence: 16.3] [Reference Citation Analysis]
26 Saito M, Seo Y, Yano Y, Momose K, Hirano H, Yoshida M, Azuma T. Reduction in non-protein respiratory quotient is related to overall survival after hepatocellular carcinoma treatment. PLoS One 2013;8:e55441. [PMID: 23520445 DOI: 10.1371/journal.pone.0055441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Hanai T, Shiraki M, Imai K, Suetsugu A, Takai K, Shimizu M. Late Evening Snack with Branched-Chain Amino Acids Supplementation Improves Survival in Patients with Cirrhosis. J Clin Med 2020;9:E1013. [PMID: 32260139 DOI: 10.3390/jcm9041013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Patel MV, Patel KB, Gupta S, Michalsen A, Stapelfeldt E, Kessler CS. A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study. Evid Based Complement Alternat Med 2015;2015:613182. [PMID: 26339267 DOI: 10.1155/2015/613182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
29 Nakaya Y, Shimohata T, Haraguchi S, Nakao T, Minaguchi J, Sumitani H, Harada N, Sakaue H. Severe catabolic state after an overnight fast in patients with chronic renal failure. Nutrition 2011;27:329-32. [DOI: 10.1016/j.nut.2010.04.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
30 Higashi T, Hayashi H, Kaida T, Arima K, Takeyama H, Taki K, Izumi D, Tokunaga R, Kosumi K, Nakagawa S, Okabe H, Imai K, Nitta H, Hashimoto D, Chikamoto A, Beppu T, Baba H. Prognostic Impact of Visceral Fat Amount and Branched-Chain Amino Acids (BCAA) in Hepatocellular Carcinoma. Ann Surg Oncol 2015;22 Suppl 3:S1041-7. [PMID: 26305023 DOI: 10.1245/s10434-015-4796-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
31 Emese - Katalin K, Carmen CAO. Treatment Possibilities of Muscle Cramps in Patients with Liver Cirrhosis. Internal Medicine 2021;18:35-52. [DOI: 10.2478/inmed-2021-0189] [Reference Citation Analysis]
32 Moctezuma-Velázquez C, García-Juárez I, Soto-Solís R, Hernández-Cortés J, Torre A. Nutritional assessment and treatment of patients with liver cirrhosis. Nutrition. 2013;29:1279-1285. [PMID: 23867207 DOI: 10.1016/j.nut.2013.03.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
33 D'Alessandro MCO, Gomes AD, Morais JF, Mizubuti YGG, Silva TAD, Fernandes SM, Mendes LL, Correia MITD, Generoso SV. SHORT-TERM EFFECT OF WHEY PROTEIN SUPPLEMENTATION ON THE QUALITY OF LIFE OF PATIENTS WAITING FOR LIVER TRANSPLANTATION: A DOUBLE BLINDED RANDOMIZED CLINICAL TRIAL. Arq Bras Cir Dig 2021;34:e1596. [PMID: 34669886 DOI: 10.1590/0102-672020210002e1596] [Reference Citation Analysis]
34 Sorrentino P, Castaldo G, Tarantino L, Bracigliano A, Perrella A, Perrella O, Fiorentino F, Vecchione R, D' Angelo S. Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis. J Gastroenterol Hepatol 2012;27:813-22. [PMID: 22142548 DOI: 10.1111/j.1440-1746.2011.07043.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
35 Moriwaki H, Shiraki M, Fukushima H, Shimizu M, Iwasa J, Naiki T, Nagaki M. Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res. 2008;38:S102-S106. [PMID: 19125940 DOI: 10.1111/j.1872-034x.2008.00434.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
36 Yoshida D, Nagao Y, Tomikawa M, Kawanaka H, Akahoshi T, Kinjo N, Uehara H, Hashimoto N, Hashizume M, Maehara Y. Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients. Hepatol Int. 2011;Epub ahead of print. [PMID: 21959984 DOI: 10.1007/s12072-011-9315-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
37 Fallahzadeh MA, Rahimi RS. Hepatic Encephalopathy and Nutrition Influences: A Narrative Review. Nutr Clin Pract 2020;35:36-48. [PMID: 31872484 DOI: 10.1002/ncp.10458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
38 Michitaka K, Hiraoka A, Kume M, Uehara T, Hidaka S, Ninomiya T, Hasebe A, Miyamoto Y, Ichiryu M, Tanihira T. Amino acid imbalance in patients with chronic liver diseases. Hepatol Res. 2010;40:393-398. [PMID: 20236360 DOI: 10.1111/j.1872-034x.2009.00614.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
39 Saito M, Seo Y, Yano Y, Miki A, Yoshida M, Azuma T. Short-term reductions in non-protein respiratory quotient and prealbumin can be associated with the long-term deterioration of liver function after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. J Gastroenterol 2012;47:704-14. [DOI: 10.1007/s00535-012-0535-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
40 Sakai Y, Iwata Y, Enomoto H, Saito M, Yoh K, Ishii A, Takashima T, Aizawa N, Ikeda N, Tanaka H. Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment. J Gastroenterol. 2015;50:109-118. [PMID: 24633624 DOI: 10.1007/s00535-014-0950-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
41 Léon CDG. Comment on: Nocturnal Nutritional Supplementation Improves Total Body Protein Status of Patients With Liver Cirrhosis: A Randomized 12-Month Trial. Nutr Clin Pract 2009;24:104-6. [DOI: 10.1177/0884533608329709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Hidaka H, Nakazawa T, Kutsukake S, Yamazaki Y, Aoki I, Nakano S, Asaba N, Minamino T, Takada J, Tanaka Y. The efficacy of nocturnal administration of branched-chain amino acid granules to improve quality of life in patients with cirrhosis. J Gastroenterol. 2013;48:269-276. [PMID: 22825550 DOI: 10.1007/s00535-012-0632-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
43 Bozeman MC, Benns MV, Mcclave SA, Miller KR, Jones CM. When Can Nutritional Therapy Impact Liver Disease? Curr Gastroenterol Rep 2014;16. [DOI: 10.1007/s11894-014-0411-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Dos Santos ALS, Anastácio LR. The impact of L-branched-chain amino acids and L-leucine on malnutrition, sarcopenia, and other outcomes in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol 2021;15:181-94. [PMID: 32993404 DOI: 10.1080/17474124.2021.1829470] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Sugihara K, Yamanaka-okumura H, Teramoto A, Urano E, Katayama T, Mori H, Utsunomiya T, Shimada M, Takeda E. Recovery pattern of non-protein respiratory quotient and non-esterified fatty acids after liver resection. Nutrition 2014;30:443-8. [DOI: 10.1016/j.nut.2013.09.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
46 Salim T, Stark SA, Duarte-rojo A. Food as Therapy for Frailty. Curr Hepatology Rep 2020;19:23-9. [DOI: 10.1007/s11901-020-00509-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Sun Y, Yang Z, Tan H. Perioperative nutritional support and fluid therapy in patients with liver diseases. Hepatobiliary Surg Nutr 2014;3:140-8. [PMID: 25019075 DOI: 10.3978/j.issn.2304-3881.2014.04.05] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Michitaka K, Tokumoto Y, Uesugi K, Kisaka Y, Hirooka M, Konishi I, Mashiba T, Abe M, Hiasa Y, Matsuura B, Horiike N, Shoda T, Onji M. Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatology Research 2008;38:1069-75. [DOI: 10.1111/j.1872-034x.2008.00374.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
49 Gao R, Gao F, Li G, Hao JY. Health-related quality of life in chinese patients with chronic liver disease. Gastroenterol Res Pract. 2012;2012:516140. [PMID: 22701477 DOI: 10.1155/2012/516140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
50 Holeček M, Vodeničarovová M. Effects of branched-chain amino acids on muscles under hyperammonemic conditions. J Physiol Biochem 2018;74:523-30. [DOI: 10.1007/s13105-018-0646-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
51 Kuwahata M, Kubota H, Kanouchi H, Ito S, Ogawa A, Kobayashi Y, Kido Y. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease. Nutr Res. 2012;32:522-529. [PMID: 22901560 DOI: 10.1016/j.nutres.2012.06.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
52 Ramos-tovar E, Muriel P. Does Nutrition Matter in Liver Disease? Liver Pathophysiology. Elsevier; 2017. pp. 743-59. [DOI: 10.1016/b978-0-12-804274-8.00053-9] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
53 Bianchi G, Marzocchi R, Lorusso C, Ridolfi V, Marchesini G. Nutritional treatment of chronic liver failure. Hepatol Res. 2008;38 Suppl 1:S93-S101. [PMID: 19125960 DOI: 10.1111/j.1872-034x.2008.00433.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
54 Kitajima Y, Takahashi H, Akiyama T, Murayama K, Iwane S, Kuwashiro T, Tanaka K, Kawazoe S, Ono N, Eguchi T, Anzai K, Eguchi Y. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis. J Gastroenterol. 2018;53:427-437. [PMID: 28741271 DOI: 10.1007/s00535-017-1370-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
55 Hiraoka A, Kato M, Marui K, Murakami T, Onishi K, Adachi T, Matsuoka J, Ueki H, Yoshino T, Tsuruta M, Aibiki T, Okudaira T, Kuroda T, Iwasaki R, Suga Y, Miyata H, Ninomiya T, Hirooka M, Abe M, Matsuura B, Michitaka K, Hiasa Y. Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker. Cancer Med 2021;10:3584-92. [PMID: 33960691 DOI: 10.1002/cam4.3908] [Reference Citation Analysis]
56 Sano A, Tsuge S, Kakazu E, Iwata T, Ninomiya M, Tsuruoka M, Inoue J, Masamune A. Plasma free amino acids are associated with sarcopenia in the course of hepatocellular carcinoma recurrence. Nutrition 2021;84:111007. [PMID: 33745507 DOI: 10.1016/j.nut.2020.111007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. Transl Gastroenterol Hepatol 2018;3:47. [PMID: 30148232 DOI: 10.21037/tgh.2018.07.06] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
58 Plank LD, Gane EJ, Peng S, Muthu C, Mathur S, Gillanders L, Mcilroy K, Donaghy AJ, Mccall JL. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12-month trial. Hepatology 2008;48:557-66. [DOI: 10.1002/hep.22367] [Cited by in Crossref: 163] [Cited by in F6Publishing: 130] [Article Influence: 11.6] [Reference Citation Analysis]
59 Meng J, Zhong J, Zhang H, Zhong W, Huang Z, Jin Y, Xu J. Pre-, peri-, and postoperative oral administration of branched-chain amino acids for primary liver cancer patients for hepatic resection: a systematic review. Nutr Cancer. 2014;66:517-522. [PMID: 24033366 DOI: 10.1080/01635581.2013.780628] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
60 Zelber-Sagi S, Ivancovsky-Wajcman D, Rabinowich L, Bentov I, Deutsch L. Nutritional Evaluation and Treatment of the Cirrhotic Patient. Clin Liver Dis 2021;25:373-92. [PMID: 33838856 DOI: 10.1016/j.cld.2021.01.007] [Reference Citation Analysis]
61 Rattanachaiwong S, Singer P. Indirect calorimetry as point of care testing. Clin Nutr 2019;38:2531-44. [PMID: 30670292 DOI: 10.1016/j.clnu.2018.12.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
62 Rivera Irigoin R, Abilés J. [Nutritional support in patients with liver cirrhosis]. Gastroenterol Hepatol. 2012;35:594-601. [PMID: 22657567 DOI: 10.1016/j.gastrohep.2012.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
63 Kawaguchi T, Taniguchi E, Sata M. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis. Nutr Clin Pract. 2013;28:580-588. [PMID: 23945292 DOI: 10.1177/0884533613496432] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
64 Macías-Rodríguez RU, Ruiz-Margáin A, Román-Calleja BM, Espin-Nasser ME, Flores-García NC, Torre A, Galicia-Hernández G, Rios-Torres SL, Fernández-del-Rivero G, Orea-Tejeda A, Lozano-Cruz OA. Effect of non-alcoholic beer, diet and exercise on endothelial function, nutrition and quality of life in patients with cirrhosis. World J Hepatol 2020; 12(12): 1299-1313 [PMID: 33442456 DOI: 10.4254/wjh.v12.i12.1299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Minemura M, Tajiri K, Shimizu Y. Systemic abnormalities in liver disease. World J Gastroenterol 2009; 15(24): 2960-2974 [PMID: 19554648 DOI: 10.3748/wjg.15.2960] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
66 Takeshita S, Ichikawa T, Nakao K, Miyaaki H, Shibata H, Matsuzaki T, Muraoka T, Honda T, Otani M, Akiyama M, Miuma S, Ozawa E, Fujimito M, Eguchi K. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Nutr Res. 2009;29:89-93. [PMID: 19285598 DOI: 10.1016/j.nutres.2008.12.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
67 Korenaga K, Korenaga M, Uchida K, Yamasaki T, Sakaida I. Effects of a late evening snack combined with α-glucosidase inhibitor on liver cirrhosis. Hepatology Research 2008;38:1087-97. [DOI: 10.1111/j.1872-034x.2008.00391.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
68 Kato A, Tanaka H, Kawaguchi T, Kanazawa H, Iwasa M, Sakaida I, Moriwaki H, Murawaki Y, Suzuki K, Okita K. Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open-label study. Hepatol Res. 2013;43:452-458. [PMID: 22994429 DOI: 10.1111/j.1872-034x.2012.01092.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
69 Ohfuji S, Fukushima W, Tanaka T, Habu D, Takeda T, Tamori A, Sakaguchi H, Seki S, Kawada N, Nishiguchi S, Shiomi S, Hirota Y. Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C? Hepatol Res 2008;38:860-8. [PMID: 18507689 DOI: 10.1111/j.1872-034X.2008.00355.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Uojima H, Sakurai S, Hidaka H, Kinbara T, Sung JH, Ichita C, Tokoro S, Masuda S, Sasaki A, Koizumi K, Egashira H, Kako M, Kobayashi S. Effect of branched-chain amino acid supplements on muscle strength and muscle mass in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2017;29:1402-7. [PMID: 28984678 DOI: 10.1097/MEG.0000000000000968] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
71 Johnson TM, Overgard EB, Cohen AE, Dibaise JK. Nutrition Assessment and Management in Advanced Liver Disease. Nutr Clin Pract 2013;28:15-29. [DOI: 10.1177/0884533612469027] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 10.0] [Reference Citation Analysis]
72 Naseer M, Turse EP, Syed A, Dailey FE, Zatreh M, Tahan V. Interventions to improve sarcopenia in cirrhosis: A systematic review. World J Clin Cases 2019; 7(2): 156-170 [PMID: 30705893 DOI: 10.12998/wjcc.v7.i2.156] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
73 Holeček M. The role of skeletal muscle in the pathogenesis of altered concentrations of branched-chain amino acids (valine, leucine, and isoleucine) in liver cirrhosis, diabetes, and other diseases. Physiol Res 2021;70:293-305. [PMID: 33982576 DOI: 10.33549/physiolres.934648] [Reference Citation Analysis]
74 Holeček M. Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation. Nutrition 2017;41:80-5. [PMID: 28760433 DOI: 10.1016/j.nut.2017.04.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
75 Harima Y, Yamasaki T, Hamabe S, Saeki I, Okita K, Terai S, Sakaida I. Effect of a late evening snack using branched-chain amino acid-enriched nutrients in patients undergoing hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. Hepatol Res. 2010;40:574-584. [PMID: 20618455 DOI: 10.1111/j.1872-034x.2010.00665.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
76 Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. World J Gastroenterol 2013; 19(43): 7620-7629 [PMID: 24282351 DOI: 10.3748/wjg.v19.i43.7620] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 82] [Article Influence: 10.3] [Reference Citation Analysis]
77 Fan CL, Wu YJ, Duan ZP, Zhang B, Dong PL, Ding HG. Resting energy expenditure and glucose, protein and fat oxidation in severe chronic virus hepatitis B patients. World J Gastroenterol 2008; 14(27): 4365-4369 [PMID: 18666327 DOI: 10.3748/wjg.14.4365] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
78 Suzuki K, Endo R, Takikawa Y, Moriyasu F, Aoyagi Y, Moriwaki H, Terai S, Sakaida I, Sakai Y, Nishiguchi S, Ishikawa T, Takagi H, Naganuma A, Genda T, Ichida T, Takaguchi K, Miyazawa K, Okita K. Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial. Hepatol Res. 2018;48:411-423. [PMID: 29235218 DOI: 10.1111/hepr.13045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
79 Shiraki M, Nishiguchi S, Saito M, Fukuzawa Y, Mizuta T, Kaibori M, Hanai T, Nishimura K, Shimizu M, Tsurumi H, Moriwaki H. Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011: Nutrition and QOL of cirrhotics in 2007-2011. Hepatology Research 2013;43:106-12. [DOI: 10.1111/hepr.12004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
80 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 18.3] [Reference Citation Analysis]
81 Cheung K, Lee SS, Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol. 2012;10:117-125. [PMID: 21893127 DOI: 10.1016/j.cgh.2011.08.016] [Cited by in Crossref: 159] [Cited by in F6Publishing: 147] [Article Influence: 14.5] [Reference Citation Analysis]
82 Abdelsayed GG. Diets in Encephalopathy. Clinics in Liver Disease 2015;19:497-505. [DOI: 10.1016/j.cld.2015.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
83 Takami T, Yamasaki T, Saeki I, Matsumoto T, Suehiro Y, Sakaida I. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function. World J Gastroenterol 2016; 22(32): 7252-7263 [PMID: 27621572 DOI: 10.3748/wjg.v22.i32.7252] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
84 Thiele M, Askgaard G, Timm HB, Hamberg O, Gluud LL. Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort. Hepat Res Treat 2013;2013:479639. [PMID: 24490061 DOI: 10.1155/2013/479639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
85 Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology. 2011;54:1063-1070. [PMID: 21563202 DOI: 10.1002/hep.24412] [Cited by in Crossref: 191] [Cited by in F6Publishing: 173] [Article Influence: 17.4] [Reference Citation Analysis]
86 Bémeur C, Desjardins P, Butterworth RF. Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure. J Nutr Metab. 2010;2010:489823. [PMID: 21234351 DOI: 10.1155/2010/489823] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
87 Kawaguchi T. Free fatty acid level is a new hepatic fuel meter. Hepatol Res 2014;44:176-8. [PMID: 24499348 DOI: 10.1111/hepr.12144] [Reference Citation Analysis]
88 Toshikuni N, Arisawa T, Tsutsumi M. Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol 2014; 20(23): 7286-7297 [PMID: 24966599 DOI: 10.3748/wjg.v20.i23.7286] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
89 Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol 2012;27:430-41. [PMID: 22004479 DOI: 10.1111/j.1440-1746.2011.06951.x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 106] [Article Influence: 12.9] [Reference Citation Analysis]
90 Ichikawa T, Naota T, Miyaaki H, Miuma S, Isomoto H, Takeshima F, Nakao K. Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance. Hepatol Res. 2010;40:971-978. [PMID: 20887332 DOI: 10.1111/j.1872-034x.2010.00701.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
91 Plauth M, Schütz T. Branched-chain amino acids in liver disease: new aspects of long known phenomena. Curr Opin Clin Nutr Metab Care. 2011;14:61-66. [PMID: 21088568 DOI: 10.1097/mco.0b013e3283413726] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
92 Juakiem W, Torres DM, Harrison SA. Nutrition in cirrhosis and chronic liver disease. Clin Liver Dis. 2014;18:179-190. [PMID: 24274873 DOI: 10.1016/j.cld.2013.09.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
93 Yamanaka-Okumura H, Nakamura T, Miyake H, Takeuchi H, Katayama T, Morine Y, Imura S, Shimada M, Takeda E. Effect of long-term late-evening snack on health-related quality of life in cirrhotic patients. Hepatol Res. 2010;40:470-476. [PMID: 20412329 DOI: 10.1111/j.1872-034x.2010.00637.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
94 Kato A, Suzuki K. Is diabetes mellitus the critical factor for the effect of a late evening snack? Hepatology Research 2007;37:596-7. [DOI: 10.1111/j.1872-034x.2007.00138.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
95 Imura S, Shimada M, Utsunomiya T, Morine Y, Ikemoto T, Mori H, Hanaoka J, Iwahashi S, Saito Y, Yamanaka-okumura H, Takeda E. Impact of splenectomy in patients with liver cirrhosis: Results from 18 patients in a single center experience: Splenectomy for cirrhotic patients. Hepatology Research 2010;40:894-900. [DOI: 10.1111/j.1872-034x.2010.00688.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
96 Shiraki M, Terakura Y, Iwasa J, Shimizu M, Miwa Y, Murakami N, Nagaki M, Moriwaki H. Elevated serum tumor necrosis factor-alpha and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis. Nutrition. 2010;26:269-275. [PMID: 19695831 DOI: 10.1016/j.nut.2009.04.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
97 Hou W, Li J, Lu J, Wang JH, Zhang FY, Yu HW, Zhang J, Yao QW, Wu J, Shi SY, Mager DR, Meng QH. Effect of a carbohydrate-containing late-evening snack on energy metabolism and fasting substrate utilization in adults with acute-on-chronic liver failure due to Hepatitis B. Eur J Clin Nutr 2013;67:1251-6. [PMID: 24045789 DOI: 10.1038/ejcn.2013.163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
98 Koretz RL. JPEN Journal Club 5. Review articles. JPEN J Parenter Enteral Nutr 2014;38:640-2. [PMID: 24951613 DOI: 10.1177/0148607113514448] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
99 Sato S, Amano N, Sato S, Kita Y, Ikeda Y, Kabemura D, Murata A, Yatagai N, Tsuzura H, Shimada Y, Genda T. Elevated serum tyrosine concentration is associated with a poor prognosis among patients with liver cirrhosis. Hepatol Res 2021;51:786-95. [PMID: 33964118 DOI: 10.1111/hepr.13651] [Reference Citation Analysis]
100 Tsuda Y, Fukui H, Sujishi T, Ohama H, Tsuchimoto Y, Asai A, Fukunisi S, Higuchi K. Is administrating branched-chain amino acid-enriched nutrition achieved symptom-free in malnourished cirrhotic patients? J Clin Biochem Nutr 2014;54:51-4. [PMID: 24426191 DOI: 10.3164/jcbn.13-64] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
101 Kakazu E, Ueno Y, Kondo Y, Fukushima K, Shiina M, Inoue J, Tamai K, Ninomiya M, Shimosegawa T. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis. Hepatology. 2009;50:1936-1945. [PMID: 19885880 DOI: 10.1002/hep.23248] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
102 Merli M, Giusto M, Giannelli V, Lucidi C, Riggio O. Nutritional status and liver transplantation. J Clin Exp Hepatol 2011;1:190-8. [PMID: 25755385 DOI: 10.1016/S0973-6883(11)60237-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
103 Macías-Rodríguez RU, Ruiz-Margáin A, Román-Calleja BM, Moreno-Tavarez E, Weber-Sangri L, González-Arellano MF, Fernández-Del-Rivero G, Ramírez-Soto K. Exercise prescription in patients with cirrhosis: Recommendations for clinical practice. Rev Gastroenterol Mex (Engl Ed) 2019;84:326-43. [PMID: 31262552 DOI: 10.1016/j.rgmx.2019.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
104 Mehta SS, Fallon MB. Muscle Cramps in Liver Disease. Clinical Gastroenterology and Hepatology 2013;11:1385-91. [DOI: 10.1016/j.cgh.2013.03.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
105 Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in Patients with Liver Cirrhosis. Nutrients 2021;13:540. [PMID: 33562292 DOI: 10.3390/nu13020540] [Reference Citation Analysis]
106 Li MH, Feng X, Deng Ba DJ, Chen C, Ruan LY, Xing YX, Chen LY, Zhong GJ, Wang JS. Hepatoprotection of Herpetospermum caudigerum Wall. against CCl4-induced liver fibrosis on rats. J Ethnopharmacol 2019;229:1-14. [PMID: 30268654 DOI: 10.1016/j.jep.2018.09.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
107 Wada S, Yamanaka-Okumura H, Katayama T, Morine Y, Imura S, Shimada M. Major liver resection reduces nonprotein respiratory quotient and increases nonesterified fatty acid at postoperative day 14 in patients with hepatocellular carcinoma. Clin Nutr ESPEN 2018;23:194-9. [PMID: 29460798 DOI: 10.1016/j.clnesp.2017.10.001] [Reference Citation Analysis]
108 Chen JC, Wang LC, Kuo HT, Fang YC, Lee HF. Late-evening snacking improves liver functions in patients with liver cirrhosis: A meta-analysis of randomized controlled trials. J Gastroenterol and Hepatol. 2019;. [PMID: 30883904 DOI: 10.1111/jgh.14665] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
109 Yasutake K, Kohjima M, Nakashima M, Kotoh K, Nakamuta M, Enjoji M. Nutrition therapy for liver diseases based on the status of nutritional intake. Gastroenterol Res Pract 2012;2012:859697. [PMID: 23197979 DOI: 10.1155/2012/859697] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
110 Kwarta E, Nagle S, Welstead L. Update on Malnutrition in Liver Cirrhosis: Assessment and Treatment. Curr Hepatology Rep 2014;13:24-34. [DOI: 10.1007/s11901-014-0230-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
111 Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition. 2010;26:482-490. [PMID: 20071143 DOI: 10.1016/j.nut.2009.06.027] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 8.7] [Reference Citation Analysis]
112 Nakanishi K, Namisaki T, Mashitani T, Kaji K, Ozaki K, Saikawa S, Sato S, Inoue T, Sawada Y, Kitagawa K, Takaya H, Shimozato N, Kawaratani H, Moriya K, Akahane T, Mitoro A, Yoshiji H. Late-Evening Snack with Branched-Chain Amino Acid-Enriched Nutrients Does Not Always Inhibit Overt Diabetes in Patients with Cirrhosis: A Pilot Study. Nutrients 2019;11:E2140. [PMID: 31500257 DOI: 10.3390/nu11092140] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
113 Tsiaousi ET, Hatzitolios AI, Trygonis SK, Savopoulos CG. Malnutrition in end stage liver disease: recommendations and nutritional support. J Gastroenterol Hepatol. 2008;23:527-533. [PMID: 18397483 DOI: 10.1111/j.1440-1746.2008.05369.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
114 Koretz RL, Avenell A, Lipman TO. Nutritional support for liver disease. Cochrane Database Syst Rev. 2012;5:CD008344. [PMID: 22592729 DOI: 10.1002/14651858.CD008344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Amodio P, Bemeur C, Butterworth R, Cordoba J, Kato A, Montagnese S, Uribe M, Vilstrup H, Morgan MY. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology. 2013;58:325-336. [PMID: 23471642 DOI: 10.1002/hep.26370] [Cited by in Crossref: 219] [Cited by in F6Publishing: 174] [Article Influence: 24.3] [Reference Citation Analysis]
116 Yao CK, Fung J, Chu NHS, Tan VPY. Dietary Interventions in Liver Cirrhosis. J Clin Gastroenterol. 2018;52:663-673. [PMID: 29912757 DOI: 10.1097/mcg.0000000000001071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
117 Ferreira LG, Anastácio LR, Correia MI. The impact of nutrition on cirrhotic patients awaiting liver transplantation. Curr Opin Clin Nutr Metab Care 2010;13:554-61. [PMID: 20531175 DOI: 10.1097/MCO.0b013e32833b64d2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
118 Holecek M, Kandar R, Sispera L, Kovarik M. Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle. Amino Acids 2011;40:575-84. [PMID: 20614225 DOI: 10.1007/s00726-010-0679-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
119 Sano A, Kakazu E, Morosawa T, Inoue J, Kogure T, Ninomiya M, Iwata T, Umetsu T, Nakamura T, Takai S, Shimosegawa T. The profiling of plasma free amino acids and the relationship between serum albumin and plasma-branched chain amino acids in chronic liver disease: a single-center retrospective study. J Gastroenterol 2018;53:978-88. [PMID: 29380062 DOI: 10.1007/s00535-018-1435-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
120 Saito M, Seo Y, Yano Y, Miki A, Yoshida M, Azuma T. A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment. J Gastroenterol 2012;47:1134-42. [DOI: 10.1007/s00535-012-0577-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]